Statistics

Market Data · Functional Mushrooms Functional Mushroom Market Statistics 2026: Lion’s Mane, Reishi & Chaga Trends Last Updated: April 2026 Functional mushrooms — species consumed primarily for their bioactive compounds and potential health benefits rather than culinary flavor — have moved from niche health stores to mainstream grocery aisles and coffee shops in less than a decade. Lion’s mane, reishi, chaga, cordyceps, and turkey tail are the most commercially significant species, available in a rapidly expanding range of formats: capsules, powders, coffee blends, gummies, tinctures, and ready-to-drink beverages. Driven by consumer interest in adaptogens, cognitive performance, and immune health, this segment is growing significantly faster than the broader edible mushroom market. This page compiles the most current market size, growth rate, and consumer trend data from Grand View Research, Mordor Intelligence, and related market research, providing a reliable statistical reference for the functional mushroom sector in 2026. ...

Market Data · Home Growing Home Mushroom Growing Statistics 2026: Market Size & Hobbyist Growth Last Updated: April 2026 Home mushroom cultivation has grown from a niche hobbyist activity into a thriving consumer market segment, fueled by the convergence of several trends: rising food costs, growing interest in self-sufficiency and sustainable living, the explosion of functional mushroom awareness, and the increasing ease and accessibility of ready-to-grow kits. The COVID-19 pandemic (2020–2021) was a watershed moment for the category, dramatically accelerating interest in home food production. Online communities dedicated to mushroom cultivation now number in the millions of members globally. The home mushroom growing market spans grow kits, pre-sterilized substrate bags, spawn (spores and mycelium), equipment, and educational resources. This page compiles market size estimates, hobbyist growth indicators, product category data, and demographic information from Grand View Research, Mordor Intelligence, USDA, and consumer research through 2026. ...

Policy Reform · Clinical Research Magic Mushroom Legalization Statistics 2026: States Decriminalizing & Clinical Progress Last Updated: May 2026 The landscape of psilocybin policy reform is shifting faster than at any point in the past 50 years. Oregon became the first U.S. state to legalize psilocybin for therapeutic use in 2020, Colorado followed with decriminalization in 2022, and more than 20 cities across the country have passed local measures deprioritizing enforcement. Meanwhile, the FDA has granted Breakthrough Therapy Designation to psilocybin for treatment-resistant depression, and major Phase 3 clinical trials are advancing toward potential federal approval. This page provides the latest statistics on legalization, decriminalization, clinical trial data, and public opinion around psilocybin access in 2026. ...

Research Data · Supplement Market Medicinal Mushroom Statistics 2026: Health Claims, Supplement Sales & Evidence Last Updated: April 2026 Medicinal mushrooms — species used for their documented or purported therapeutic properties — represent one of the fastest-growing segments in the global dietary supplement and nutraceutical markets. The primary species of commercial significance include turkey tail (Trametes versicolor), reishi (Ganoderma lucidum), lion’s mane (Hericium erinaceus), maitake (Grifola frondosa), shiitake (Lentinula edodes), and chaga (Inonotus obliquus). While many of these species have centuries-long histories of use in Asian traditional medicine, the current era is characterized by a rapid expansion of scientific research investigating their bioactive compounds — primarily beta-glucan polysaccharides, triterpenoids, and hericenones — and by a $7+ billion global supplement market. This page compiles market size, supplement sales, published clinical evidence, and regulatory data from Grand View Research, Mordor Intelligence, PubMed, NIH, and related sources through 2026. ...

Dietary Data · Consumer Trends Mushroom Consumption Statistics 2026: Per Capita Intake & Dietary Trends Last Updated: May 2026 Mushrooms have become a staple ingredient in kitchens worldwide, but consumption patterns vary dramatically by region, culture, and dietary preference. While East Asian countries lead the world in per-capita mushroom intake, consumption in North America and Europe has risen steadily — driven by plant-based eating trends, functional food awareness, and a growing appetite for specialty species beyond the common white button. This page aggregates the latest consumption statistics from the FAO, American Mushroom Institute, Grand View Research, and national dietary surveys to provide a clear picture of how mushroom eating habits are evolving around the world in 2026. ...

Industry Data · Market Research Mushroom Industry Statistics 2026: Global Market Size, Production & Growth Last Updated: April 2026 The global mushroom industry has grown into a multi-billion-dollar sector spanning food production, pharmaceuticals, nutraceuticals, and materials science. Driven by rising consumer interest in plant-based diets, functional foods, and sustainable agriculture, mushroom production has expanded rapidly across both developing and developed markets. China dominates global supply, contributing roughly 75–80% of all cultivated mushrooms, while the United States, Europe, and Asia-Pacific continue to register strong demand growth. This page compiles the most current statistics from the USDA, United Nations Food and Agriculture Organization (FAO), Grand View Research, Mordor Intelligence, and the American Mushroom Institute to give researchers, growers, and industry professionals a reliable reference for the 2026 market landscape. ...

Research Data · Clinical Science · Policy Psilocybin Research Statistics 2026: Clinical Trials, Legalization & Mental Health Data Last Updated: April 2026 Note: This page presents factual data from peer-reviewed journals, government clinical trial registries, and policy records. Psilocybin remains a Schedule I controlled substance under U.S. federal law. Information here is provided for research and educational reference only. Psilocybin, the primary psychoactive compound in several mushroom species (most commonly Psilocybe cubensis), has been the subject of a significant and rapidly expanding clinical research program since the early 2010s. Following decades of restricted research access, the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation to psilocybin for treatment-resistant depression in 2018 and for major depressive disorder in 2019. These designations catalyzed a wave of Phase 2 and Phase 3 clinical trials across North America, Europe, and Australia. This page compiles key statistics on clinical trial activity, published efficacy data, regulatory status, and policy developments from ClinicalTrials.gov, MAPS, PubMed, the New England Journal of Medicine, and government legislative records through early 2026. ...

USDA Data · Domestic Production U.S. Mushroom Production Statistics 2026: Farms, Output & Top Growing States Last Updated: April 2026 The United States is one of the world’s most valuable mushroom-producing nations, ranking among the top five globally by production value despite producing a far smaller volume than China. The USDA National Agricultural Statistics Service (NASS) publishes an annual Mushroom Industry report providing detailed production, sales, price, and farm operation data for the U.S. commercial mushroom industry. This page compiles key statistics from the USDA NASS Mushroom Industry Report (most recent: 2023–2024 marketing season), supplemented by data from the American Mushroom Institute, the USDA Economic Research Service, and the USDA Foreign Agricultural Service. It provides researchers, growers, policymakers, and industry analysts with a reliable reference for U.S. mushroom production statistics through 2026. ...